EPM
GILD icon

Equitec Proprietary Markets’s Gilead Sciences GILD Stock Holding History

Equitec Proprietary Markets’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-300
Closed -$22K – 320
2021
Q4 		$22K Buy
+300
New +$20.7K ﹤0.01% 319
2016
Q3 		– Sell
-1,500
Closed -$125K – 142
2016
Q2 		$125K Buy
+1,500
New +$133K 0.01% 109
2015
Q1 		– Sell
-13,620
Closed -$1.28M – 306
2014
Q4 		$1.28M Buy
+13,620
New +$1.41M 0.06% 77

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Equitec Proprietary Markets's GILD Position: Q1 2022 in Review

Equitec Proprietary Markets sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 300 shares — an estimated $22K sold.

Equitec Proprietary Markets first reported a position in GILD in Q4 2014 and held it in 3 quarters. The position peaked at $1.28M in Q4 2014. 1,600 funds tracked by Wall St. Rank hold GILD as of Q1 2022.

  • Equitec Proprietary Markets reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
  • Equitec Proprietary Markets sold 300 Gilead Sciences shares in Q1 2022, an estimated $22K.
  • Equitec Proprietary Markets first reported a position in Gilead Sciences in Q4 2014 and held it in 3 quarters.
  • Equitec Proprietary Markets's Gilead Sciences position peaked at $1.28M in Q4 2014.
  • 1,600 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.

Based on Equitec Proprietary Markets's 13F filing for Q1 2022, filed 22 Apr 2022.